CIMADAMORE, Alessia
CIMADAMORE, Alessia
DMED - DIPARTIMENTO DI MEDICINA
A gender-related dichotomy in bladder cancer
2022-01-01 Cimadamore, Alessia; Teoh, Jeremy Y; DI Trapani, Ettore; Krajewski, Wojciech; Tan, Wei Shen; Mori, Keiichiro; Del Giudice, Francesco; Carrion, Diego M; Moschini, Marco
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
2022-01-01 Krajewski, Wojciech; Aumatell, Júlia; Subiela, José Daniel; Nowak, Łukasz; Tukiendorf, Andrzej; Moschini, Marco; Basile, Giuseppe; Poletajew, Sławomir; Małkiewicz, Bartosz; Del Giudice, Francesco; Maggi, Martina; Chung, Benjamin I; Cimadamore, Alessia; Galosi, Andrea Benedetto; Fave, Rocco Francesco Delle; D'Andrea, David; Shariat, Shahrokh F; Hornak, Jakub; Babjuk, Marko; Chorbińska, Joanna; Teoh, Jeremy Yuen-Chun; Muilwijk, Tim; Joniau, Steven; Tafuri, Alessandro; Antonelli, Alessandro; Panunzio, Andrea; Alvarez-Maestro, Mario; Simone, Giuseppe; Mastroianni, Riccardo; Łaszkiewicz, Jan; Lonati, Chiara; Zamboni, Stefania; Simeone, Claudio; Niedziela, Łukasz; Candela, Luigi; Macek, Petr; Contieri, Roberto; Hidalgo, Beatriz Gutierrez; Rivas, Juan Gomez; Sosnowski, Roman; Mori, Keiichiro; Mir, Carmen; Soria, Francesco; González-Padilla, Daniel A; Faba, Òscar Rodriguez; Palou, Juan; Ploussard, Guillaume; Rajwa, Paweł; Hałoń, Agnieszka; Laukhtina, Ekaterina; Pradere, Benjamin; Tully, Karl; Burgos, Francisco Javier; Cidre, Miguel Ángel Jiménez; Szydełko, Tomasz
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets
2017-01-01 Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review
2021-01-01 Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Mazzucchelli, R.; Luciano, R.; Scarpelli, M.; Montorsi, F.; Montironi, R.
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies
2018-01-01 Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R.
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis
2023-01-01 Mori, K.; Yanagisawa, T.; Fukuokaya, W.; Iwatani, K.; Matsukawa, A.; Katayama, S.; Pradere, B.; Laukhtina, E.; Rajwa, P.; Moschini, M.; Albisinni, S.; Krajewski, W.; Cimadamore, A.; Del Giudice, F.; Teoh, J.; Urabe, F.; Kimura, S.; Murakami, M.; Tsuzuki, S.; Miki, J.; Miki, K.; Shariat, S. F.; Kimura, T.
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF?
2021-01-01 Mollica, V.; Rizzo, A.; Di Nunno, V.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Cimadamore, A.; Montironi, R.; Massari, F.
Agent-Based Learning Model for the Obesity Paradox in RCC
2021-01-01 Belenchia, M.; Rocchetti, G.; Maestri, S.; Cimadamore, A.; Montironi, R.; Santoni, M.; Merelli, E.
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer
2020-01-01 Mollica, V.; Di Nunno, V.; Santoni, M.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Mariani, C.; Battelli, N.; Montironi, R.; Massari, F.
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt
2021-01-01 Mollica, V.; Marchetti, A.; Rosellini, M.; Nuvola, G.; Rizzo, A.; Santoni, M.; Cimadamore, A.; Montironi, R.; Massari, F.
An update on immunotherapy in uro-oncology
2021-01-01 Cimadamore, A.; Rizzo, A.; Mollica, V.; Massari, F.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Santoni, M.; Montironi, R.
An update on investigational therapies that target STAT3 for the treatment of cancer
2021-01-01 Santoni, M.; Miccini, F.; Cimadamore, A.; Piva, F.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Battelli, N.
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
2020-01-01 Aurilio, Gaetano; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Verri, Elena; Scarpelli, Marina; Massari, Francesco; Cheng, Liang; Santoni, Matteo; Montironi, Rodolfo
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis
2023-01-01 Santoni, Matteo; Massari, Francesco; Rizzo, Alessandro; Mollica, Veronica; Cimadamore, Alessia; Montironi, Rodolfo; Battelli, Nicola
Are liver nested stromal epithelial tumors always low aggressive?
2017-01-01 Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R.
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
2022-01-01 Marletta, Stefano; Fusco, Nicola; Munari, Enrico; Luchini, Claudio; Cimadamore, Alessia; Brunelli, Matteo; Querzoli, Giulia; Martini, Maurizio; Vigliar, Elena; Colombari, Romano; Girolami, Ilaria; Pagni, Fabio; Eccher, Albino
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
2018-01-01 Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer
2018-01-01 Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R.
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial
2021-01-01 Denize, Thomas; Farah, Subrina; Cimadamore, Alessia; Flaifel, Abdallah; Walton, Emily; A Sticco-Ivins, Maura; Labaki, Chris; A Braun, David; Sun, Maxine; Wang, Evelyn; Xie, Wanling; K Choueiri, Toni; Signoretti, Sabina
Biphasic Tumors of the Urogenital Tract: Selected Topics
2019-01-01 Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A gender-related dichotomy in bladder cancer | 1-gen-2022 | Cimadamore, Alessia; Teoh, Jeremy Y; DI Trapani, Ettore; Krajewski, Wojciech; Tan, Wei Shen; Mori, Keiichiro; Del Giudice, Francesco; Carrion, Diego M; Moschini, Marco | |
| Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer | 1-gen-2022 | Krajewski, Wojciech; Aumatell, Júlia; Subiela, José Daniel; Nowak, Łukasz; Tukiendorf, Andrzej; Moschini, Marco; Basile, Giuseppe; Poletajew, Sławomir; Małkiewicz, Bartosz; Del Giudice, Francesco; Maggi, Martina; Chung, Benjamin I; Cimadamore, Alessia; Galosi, Andrea Benedetto; Fave, Rocco Francesco Delle; D'Andrea, David; Shariat, Shahrokh F; Hornak, Jakub; Babjuk, Marko; Chorbińska, Joanna; Teoh, Jeremy Yuen-Chun; Muilwijk, Tim; Joniau, Steven; Tafuri, Alessandro; Antonelli, Alessandro; Panunzio, Andrea; Alvarez-Maestro, Mario; Simone, Giuseppe; Mastroianni, Riccardo; Łaszkiewicz, Jan; Lonati, Chiara; Zamboni, Stefania; Simeone, Claudio; Niedziela, Łukasz; Candela, Luigi; Macek, Petr; Contieri, Roberto; Hidalgo, Beatriz Gutierrez; Rivas, Juan Gomez; Sosnowski, Roman; Mori, Keiichiro; Mir, Carmen; Soria, Francesco; González-Padilla, Daniel A; Faba, Òscar Rodriguez; Palou, Juan; Ploussard, Guillaume; Rajwa, Paweł; Hałoń, Agnieszka; Laukhtina, Ekaterina; Pradere, Benjamin; Tully, Karl; Burgos, Francisco Javier; Cidre, Miguel Ángel Jiménez; Szydełko, Tomasz | |
| Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets | 1-gen-2017 | Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo | |
| Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review | 1-gen-2021 | Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Mazzucchelli, R.; Luciano, R.; Scarpelli, M.; Montorsi, F.; Montironi, R. | |
| Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies | 1-gen-2018 | Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R. | |
| Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis | 1-gen-2023 | Mori, K.; Yanagisawa, T.; Fukuokaya, W.; Iwatani, K.; Matsukawa, A.; Katayama, S.; Pradere, B.; Laukhtina, E.; Rajwa, P.; Moschini, M.; Albisinni, S.; Krajewski, W.; Cimadamore, A.; Del Giudice, F.; Teoh, J.; Urabe, F.; Kimura, S.; Murakami, M.; Tsuzuki, S.; Miki, J.; Miki, K.; Shariat, S. F.; Kimura, T. | |
| Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? | 1-gen-2021 | Mollica, V.; Rizzo, A.; Di Nunno, V.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Cimadamore, A.; Montironi, R.; Massari, F. | |
| Agent-Based Learning Model for the Obesity Paradox in RCC | 1-gen-2021 | Belenchia, M.; Rocchetti, G.; Maestri, S.; Cimadamore, A.; Montironi, R.; Santoni, M.; Merelli, E. | |
| An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer | 1-gen-2020 | Mollica, V.; Di Nunno, V.; Santoni, M.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Mariani, C.; Battelli, N.; Montironi, R.; Massari, F. | |
| An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt | 1-gen-2021 | Mollica, V.; Marchetti, A.; Rosellini, M.; Nuvola, G.; Rizzo, A.; Santoni, M.; Cimadamore, A.; Montironi, R.; Massari, F. | |
| An update on immunotherapy in uro-oncology | 1-gen-2021 | Cimadamore, A.; Rizzo, A.; Mollica, V.; Massari, F.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Santoni, M.; Montironi, R. | |
| An update on investigational therapies that target STAT3 for the treatment of cancer | 1-gen-2021 | Santoni, M.; Miccini, F.; Cimadamore, A.; Piva, F.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Battelli, N. | |
| Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications | 1-gen-2020 | Aurilio, Gaetano; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Verri, Elena; Scarpelli, Marina; Massari, Francesco; Cheng, Liang; Santoni, Matteo; Montironi, Rodolfo | |
| Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis | 1-gen-2023 | Santoni, Matteo; Massari, Francesco; Rizzo, Alessandro; Mollica, Veronica; Cimadamore, Alessia; Montironi, Rodolfo; Battelli, Nicola | |
| Are liver nested stromal epithelial tumors always low aggressive? | 1-gen-2017 | Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R. | |
| Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems | 1-gen-2022 | Marletta, Stefano; Fusco, Nicola; Munari, Enrico; Luchini, Claudio; Cimadamore, Alessia; Brunelli, Matteo; Querzoli, Giulia; Martini, Maurizio; Vigliar, Elena; Colombari, Romano; Girolami, Ilaria; Pagni, Fabio; Eccher, Albino | |
| Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer | 1-gen-2018 | Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo | |
| Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer | 1-gen-2018 | Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R. | |
| Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial | 1-gen-2021 | Denize, Thomas; Farah, Subrina; Cimadamore, Alessia; Flaifel, Abdallah; Walton, Emily; A Sticco-Ivins, Maura; Labaki, Chris; A Braun, David; Sun, Maxine; Wang, Evelyn; Xie, Wanling; K Choueiri, Toni; Signoretti, Sabina | |
| Biphasic Tumors of the Urogenital Tract: Selected Topics | 1-gen-2019 | Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M |